BATS BZX Real-Time Price
As of 1:12pm ET
| -2.10 / -1.17%|
The 23 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 197.00, with a high estimate of 212.00 and a low estimate of 103.00. The median estimate represents a +10.66% increase from the last price of 178.02.
The current consensus among 26 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.